The prescribing information for two respiratory syncytial virus (RSV) vaccines will now include a warning for the increased ...

The prescribing information for Abrysvo ® (respiratory syncytial virus [RSV] vaccine) and Arexvy ® (RSV vaccine, adjuvanted) has been updated to include a new warning regarding the risk of ...

The FDA requires labeling changes to the prescribing information for Pfizer and GSK RSV vaccines to include warnings about the risk for GBS.

The U.S. Food and Drug Administration now requires and has approved safety labeling changes to the prescribing information ...

According to the FDA, the benefits of vaccination with Abrysvo and Arexvy continue to outweigh the potential risks. The prescribing information for Abrysvo ® (respiratory syncytial virus [RSV ...

The abrysvo or arexvy market's growth is expected to be significantly driven by the increasing prevalence of respiratory syncytial virus RSV infections. RSV infections primarily affect the ...

Expectant mothers will have access to free vaccines against respiratory syncytial virus (RSV) from next month under a major ...

Pregnant women across Australia will be offered a free vaccine to protect their babies against respiratory syncytial virus ...

FDA 2025 pulmonology drug alerts, including drug approvals/warnings, vaccine approvals, and medical device recalls/updates.

RSV is a contagious virus causing severe respiratory infections in infants. Vaccination during pregnancy, provides newborns ...

Pregnant women will be offered free RSV vaccines as part of the National Immunisaton Program from February 3, Health Minister ...